Document Detail

Long versus short course treatment with Metformin and Clomiphene Citrate for ovulation induction in women with PCOS.
MedLine Citation:
PMID:  18254096     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy among reproductive-aged women. Apart from infertility, women with PCOS often have other endocrine disorders, including insulin resistance,hyperinsulinaemia and hyperandrogenism. Metformin,combined with clomiphene citrate (CC), has been shown to be more effective in ovulation induction when compared with clomiphene citrate alone. The optimal duration for metformin pretreatment before initiation of clomiphene citrate, however, is unknown.
OBJECTIVES: To determine the effectiveness of short-course (less than four weeks) metformin plus CC versus long-course (four weeks or more) metformin plus CC with regard to ovulation and achievement of pregnancy in infertile PCOS women.
SEARCH STRATEGY: We searched the Cochrane Menstrual Disorders and Subfertility Group Trials Register (December 2006), the Cochrane Central Register of Controlled Trials (The Cochrane Library 2006, 2006 issue 4), MEDLINE (1950 to 7 January 2007), CINAHL (1982 to December 2006) and EMBASE (1980 to 7 January 2007).
SELECTION CRITERIA: Randomised controlled trials comparing short-course (less than four weeks) metformin plus CC versus long-course (four weeks or more) metformin plus CC for ovulation or achievement of pregnancy in infertile PCOS women.
DATA COLLECTION AND ANALYSIS: No trials were found that met the selection criteria.
MAIN RESULTS: No randomised controlled trials were identified.
AUTHORS' CONCLUSIONS: There are insufficient data to determine whether short-chouse metformin pretreatment is as effective as the conventional long-course metformin pretreatment before initiation of clomiphene citrate for ovulation induction in infertile PCOS patients. A well-designed randomised controlled trial is needed to answer this important clinical question.
S Sinawat; P Buppasiri; P Lumbiganon; P Pattanittum
Related Documents :
3758386 - Cumulative pregnancy rates for in vitro fertilization.
9547686 - Low multiple pregnancy rates and reduced frequency of cancellation after ovulation indu...
12797086 - The impact of sonographic assessment of the endometrium and meticulous hormonal monitor...
17999276 - Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in ...
6950956 - Actions of isotretinoin and etretinate on the pilosebaceous unit.
922336 - Predicting fetal death by measuring oestrogen:creatinine ratios on early morning sample...
Publication Detail:
Type:  Journal Article; Review     Date:  2008-01-23
Journal Detail:
Title:  The Cochrane database of systematic reviews     Volume:  -     ISSN:  1469-493X     ISO Abbreviation:  Cochrane Database Syst Rev     Publication Date:  2008  
Date Detail:
Created Date:  2008-02-06     Completed Date:  2008-04-14     Revised Date:  2013-06-28    
Medline Journal Info:
Nlm Unique ID:  100909747     Medline TA:  Cochrane Database Syst Rev     Country:  England    
Other Details:
Languages:  eng     Pagination:  CD006226     Citation Subset:  IM    
Khon Kaen Universtity, Obstetrics and Gynaecology, Kohn Kaen, Thailand, 40002.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Clomiphene / administration & dosage*
Drug Administration Schedule
Drug Therapy, Combination
Fertility Agents, Female / administration & dosage*
Infertility, Female / drug therapy
Metformin / administration & dosage*
Ovulation Induction / methods*
Polycystic Ovary Syndrome / complications*
Reg. No./Substance:
0/Fertility Agents, Female; 657-24-9/Metformin; 911-45-5/Clomiphene
Update In:
Cochrane Database Syst Rev. 2012;10:CD006226   [PMID:  23076922 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity...
Next Document:  Care delivery and self-management strategies for adults with epilepsy.